Key result
Percutaneous balloon mitral valvotomy using a veno-arterial loop technique successfully increased mitral valve area from 0.4 to 1.0 cm2 and reduced the mean gradient from 11 to 5 mmHg.
Why the study?
Treating rheumatic mitral stenosis with percutaneous balloon mitral valvotomy poses unique challenges in special populations like pregnant patients or those with atrial fibrillation, with limited data in pregnant women with poor valve morphology.
Does the veno-arterial loop technique facilitate successful percutaneous balloon mitral valvotomy in patients with severe rheumatic mitral stenosis when standard crossing fails?
Case Report (n=1)
Does the veno-arterial loop technique facilitate successful percutaneous balloon mitral valvotomy in patients with severe rheumatic mitral stenosis when standard crossing fails?
The veno-arterial loop technique is a feasible and safe alternative to facilitate mitral valve crossing during percutaneous balloon mitral valvotomy when standard techniques fail.
Answers are grounded in this paper and cite their sources.
May offer bailout for failed standard crossing in rheumatic mitral stenosis; hypothesis-generating and requires prospective validation.
Percutaneous balloon mitral valvotomy (PBMV) is a good and preferred therapy choice over surgical commissurotomy for patients with rheumatic mitral stenosis (MS). However, interventional cardiologists must recognize that treating patients with rheumatic MS poses unique challenges for each patient, especially in special populations such as pregnant patients or patients with arrhythmias like atrial fibrillation (AF), which can complicate procedures. Based on information from observational studies, PBMV may be a safe and efficient treatment for improving outcomes in MS women who do not have substantial subvalve illness in a specific demographic. A successful PBMV helps to tolerate hemodynamic changes during pregnancy and dramatically reduces mortality. However, there is a paucity of studies on women with poor valve morphology who are not contraindicated, and it has to be seen if PBMV is used in these situations during pregnancy. Conversely, AF leads to a lower PBMV success rate as well as worse long-term and in-hospital outcomes.
No takes yet. Share an insight, caveat, or question.
Habib et al. (2024) conducted a case report in Severe rheumatic mitral stenosis (n=1). Percutaneous balloon mitral valvotomy (PBMV) using veno-arterial loop technique was evaluated on Mitral valve area and mean mitral valve gradient. Percutaneous balloon mitral valvotomy using a veno-arterial loop technique successfully increased mitral valve area from 0.4 to 1.0 cm2 and reduced the mean gradient from 11 to 5 mmHg.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: